Treating cardiovascular risk in RA requires multidisciplinary care

Nature Reviews Rheumatology

Volumn 10, Issue 4, 2014, Pages 202-204

  Mankad, Rekha ^a   Gabriel, Sherine E ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CORTICOSTEROID; METHOTREXATE;

ARTERIAL WALL THICKNESS; ATTRIBUTABLE RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT TOOL; CLINICAL PRACTICE; DISEASE ASSOCIATION; DRUG EFFICACY; EVIDENCE BASED MEDICINE; FRAMINGHAM RISK SCORE; HIGH RISK PATIENT; HUMAN; PATIENT CARE; PATIENT MONITORING; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REYNOLDS RISK SCORE; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SHORT SURVEY; SYSTEMIC CORONARY RISK EVALUATION; ARTICLE; CARDIOLOGY; COOPERATION; RHEUMATOLOGY; RISK FACTOR;

ARTHRITIS, RHEUMATOID; CARDIOLOGY; CARDIOVASCULAR DISEASES; COOPERATIVE BEHAVIOR; HUMANS; PATIENT CARE TEAM; RHEUMATOLOGY; RISK FACTORS;

EID: 84898596438     PISSN: 17594790     EISSN: 17594804     Source Type: Journal    
DOI: 10.1038/nrrheum.2014.37     Document Type: Short Survey

References (10)

1. Sokka, T., Abelson, B. & Pincus, T. Mortality in rheumatoid arthritis: 2008 update. Clin. Exp. Rheumatol. 26 (Suppl. 51), S35-S61 (2008).
2. Crowson, C. S., Matteson, E. L., Roger, V. L., Therneau, T. M. & Gabriel, S. E. Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritis. Am. J. Cardiol. 110, 420-424 (2012).
3. Arts, E. E. A. et al. Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritis. Ann. Rheum. Dis. .
4. Crowson, C. S. et. al. Rheumatoid arthritis and cardiovascular disease. Am. Heart J. 166, 622-628 (2013).
5. Sattar, N., McCarey, D. W., Capell, H. & McInnes, I. B. Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation 108, 2957-2963 (2003).
6. Hansson, G. K. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 352, 1685-1695 (2005).
7. Choi, H. K., Hernan, M. A., Seeger, J. D., Robins, J. M. & Wolfe, F. Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet 359, 1173-1177 (2002).
8. Stein, J. H. et al. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the american society of echocardiography carotid intima-media thickness task force. Endorsed by the Society for Vascular Medicine. J. Am. Soc. Echocardiogr. 21, 93-111 (2008).
9. Tyrrell, P. N. et al. Rheumatic disease and carotid intima-media thickness: a systematic review and meta-analysis. Arterioscler. Thromb. Vasc. Biol. 30, 1014-1026 (2010).
10. Friedewald, V. E. et al. AJC editor?s consensus: rheumatoid arthritis and atherosclerotic cardiovascular disease. Am. J. Cardiol. 106, 442-447 (2010).